Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWindar Photo Regulatory News (WPHO)

Share Price Information for Windar Photo (WPHO)

Share Price is delayed by 15 minutes
Get Live Data
26.75    -0.50 (-1.83%)
Bid:
26.50
Ask:
27.00
Spread: 0.50 (1.887%)
Market Cap: £26.28m
WPHO Live PriceLast checked at - London Stock Exchange

Intraday Windar Photo Share Chart

Senior Management Appointment

13 Aug 2025 07:00

RNS Number : 0741V
Windar Photonics PLC
13 August 2025
 

13 August 2025

("Windar" or the "Company") 

Senior Management Appointment

Former Siemens and EWT Executive, Birol Yosul, appointed VP of European Sales

Windar Photonics plc (AIM: WPHO), the technology group behind the LiDAR-assisted monitoring and optimisation solution for multiple wind turbine platforms, is pleased to announce the appointment Birol Yosul as Vice President of Sales for Europe, with effect from 1 September 2025.

Birol is a highly respected sales leader with over 15 years of international experience in the wind energy sector. He brings a proven track record in business development, deep industry insight, and an extensive professional network. His previous senior roles include leadership positions at Siemens, where he worked as Technical Sales Manager, as well as Operations Manager Service Offshore Wind Power, before going on to work at Bureau Veritas, the specialist infrastructure testing, inspection and certification company. Most recently, Birol has worked as Director of Sales & Business Development for Europe at Emergya Wind Technologies B.V.

In addition to the appointment of Birol, the Company has identified a new Vice President of Sales for the Americas, which will be confirmed and announced shortly. Both appointments demonstrate the ambition to strengthen the Company's presence and reach across international markets.

Jørgen Korsgaard Jensen, CEO of Windar Photonics, commented:

"We are pleased to welcome our new Vice President of Sales for Europe. Birol 's extensive experience will be instrumental in expanding our business and customer base across European markets. Alongside our soon to be announced VP of Sales for the Americas, this marks an important step in strengthening Windar's marketing reach."

  

For further information, please contact:

Windar Photonics plc

Jørgen Korsgaard Jensen, CEO

Tel: +45 24234930

 

 

Grant Thornton UK LLP

Nominated Adviser

Philip Secrett / Harrison Clarke / Elliot Peters

Tel: +44 (0) 20 7383 5100

Dowgate Capital

Broker

James Serjeant / Russell Cook

Tel: +44 (0) 20 3903 7715

Novella Communications

Tim Robertson / Safia Colebrook

Tel: +44 (0) 20 3151 7008

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAFPAFDESEAA
Date   Source Headline
3rd Jun 202611:54 amRNSCEO Appointment, Grant of Options and RPT
28th May 202610:45 amRNSCorrection: Director/PDMR Shareholding
21st Apr 20267:00 amRNSCEO Appointment
20th Apr 202612:15 pmRNSHolding(s) in Company
20th Apr 202611:45 amRNSHolding(s) in Company
15th Apr 20267:00 amRNSTrading Update & £20m Share Subscription Facility
26th Mar 20261:30 pmRNSIssue of Equity in Lieu of Non-Executive Fees
16th Jan 20266:22 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirectorate change
23rd Dec 20257:00 amRNSTrading Statement
23rd Dec 20257:00 amRNSTrading Statement
15th Dec 20257:00 amRNSChange of Adviser
13th Nov 20259:41 amRNSHolding(s) in Company
20th Oct 20257:00 amRNSDirectorate Change
15th Sep 20257:00 amRNSHalf-year Report
8th Sep 20257:00 amRNS-RSenior Management Appointment
13th Aug 20257:00 amRNS-RSenior Management Appointment
11th Aug 20257:00 amRNSNew $2.6m Order For The US Market
1st Aug 202512:27 pmRNSResult of AGM
1st Aug 20257:00 amRNSAGM Statement
1st Jul 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNSUpdate on Expectations
9th Jun 20257:00 amRNSDirectorate Change
19th May 20257:00 amRNS-RWindar Photonics to Exhibit at CLEANPOWER 2025
30th Apr 20257:00 amRNSWind Sector Leaders Join New Advisory Board
14th Apr 20257:00 amRNSDirector/PDMR Shareholding
26th Mar 20255:19 pmRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSTrading Update and First Discreet Software Order
26th Feb 202512:41 pmRNSIssue of Equity in Lieu of Directors' Fees
31st Dec 20247:00 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSMaterial New US Order
10th Dec 20242:30 pmRNSTR-1: Notification of Major Holdings
6th Dec 20244:41 pmRNSTR-1: Notification of Major Holdings
6th Dec 20244:31 pmRNSTR-1: Notification of Major Holdings
3rd Dec 20248:00 amRNSResult of oversubscribed placing
2nd Dec 20244:35 pmRNSProposed placing to raise £5.5 million
12th Nov 20247:00 amRNSTrading Update
19th Sep 20245:34 pmRNSAIM Rule 17 Schedule 2 (G) Update
12th Sep 20247:00 amRNSUn-audited Results for the 6 months ended 30 June
5th Aug 20244:52 pmRNSResults of AGM
5th Aug 20247:00 amRNSAGM Trading Update
1st Aug 202410:44 amRNSAppointment of Broker
19th Jul 202410:36 amRNSDirectorate Change and Director Disclosures
15th Jul 20247:00 amRNSChange of Nominated Adviser
11th Jul 20249:13 amRNSPosting of Annual Report and Notice of AGM
4th Jul 20245:33 pmRNSAIM Rule 17 Schedule 2 (G) Update
1st Jul 20247:00 amRNSAudited Results, Trading Update and Notice of AGM
3rd May 202410:37 amRNSDirectors Dealing / PDMR Shareholding
22nd Apr 20249:38 amRNSDirector Dealing
18th Apr 20245:30 pmRNSDirector dealing / PDMR shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.